If we are concerned about asthma, we would fix that.
Editor's note · Context
Burgess criticizes the FDA and EPA for restricting asthma medication access.
Share & report
More from Michael Burgess
Madam Speaker, I thank my friend for yielding, and I certainly want to congratulate the gentleman from Georgia on leading his first rule as a member of the Rules Committee. While he is the newest member of the Rules Committee, he is a…
Mr. Speaker, I yield 5 minutes to the gentleman from Pennsylvania (Mr. Kelly), the sponsor of this resolution.
Mr. Speaker, I thank Dr. Bucshon from Indiana for yielding me the time on such an important reauthorization that we are undertaking today. Mr. Speaker, 2018 was the last authorization for sickle cell research. Prior to that, it had been…
Madam Speaker, I thank my friend from New York for yielding, and I thank him for leading this discussion on behalf of the Rules Committee today. I wanted to come down and speak in support of the rule, and I want to speak in support of the…





